558 related articles for article (PubMed ID: 29980179)
1. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
2. Three cases of antibody-LGI1 limbic encephalitis and review of literature.
Bing-Lei W; Jia-Hua Z; Yan L; Zan Y; Xin B; Jian-Hua S; Hui-Juan W
Int J Neurosci; 2019 Jul; 129(7):642-648. PubMed ID: 30112956
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
4. The Treatment and Follow-Up of Anti-LGI1 Limbic Encephalitis.
Yu J; Yu X; Fang S; Zhang Y; Lin W
Eur Neurol; 2016; 75(1-2):5-11. PubMed ID: 26694143
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
[No Abstract] [Full Text] [Related]
6. Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review.
Li X; Yuan J; Liu L; Hu W
BMC Neurol; 2019 Feb; 19(1):19. PubMed ID: 30732585
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
10. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
11. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
12. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
14. Natural course of LGI1 encephalitis: 3-5 years of follow-up without immunotherapy.
Szots M; Marton A; Kover F; Kiss T; Berki T; Nagy F; Illes Z
J Neurol Sci; 2014 Aug; 343(1-2):198-202. PubMed ID: 24928080
[TBL] [Abstract][Full Text] [Related]
15. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
17. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.
Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y
Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332
[TBL] [Abstract][Full Text] [Related]
18. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
Irani SR; Michell AW; Lang B; Pettingill P; Waters P; Johnson MR; Schott JM; Armstrong RJ; S Zagami A; Bleasel A; Somerville ER; Smith SM; Vincent A
Ann Neurol; 2011 May; 69(5):892-900. PubMed ID: 21416487
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
20. [A case of smoldering anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-associated limbic encephalitis with faciobrachial dystonic seizure].
Nakaoku Y; Maki T; Kanazawa K; Matsumoto R; Fukuyama H; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2013; 53(9):706-11. PubMed ID: 24097318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
